Fertility Startup Inito Wants To Use AI-Designed Antibodies To Expand At-Home Health Tests
Inito raises $29M to expand AI-powered at-home diagnostics with new AI-designed antibodies.
Matilda
Fertility Startup Inito Wants To Use AI-Designed Antibodies To Expand At-Home Health Tests
Inito’s Big AI Bet Could Change At-Home Health Testing Inito just raised a massive $29 million Series B round—and the company says this funding will accelerate its plan to bring AI-designed antibodies into at-home diagnostics. For anyone searching how Inito works, what makes its fertility tracker different, or why AI matters in hormone testing, the short answer is accuracy and scale. In the first few years of launching its fertility monitor, Inito built a reputation for turning lab-grade hormone insights into something people could access from home. Now, with new capital and fast growth, the startup is aiming to expand from fertility into broad, AI-powered home health testing. Credit: Inito The Rise of Inito: From a Fertility Monitor to a Scalable Health Platform When Inito launched its first fertility monitor in 2021, its mission was simple: bring lab-quality quantitative hormone testing to consumers. Unlike traditional ovulation tests that only track estrogen and luteinizing hormone (LH…
